Trial
NCT04725812
Complement Regulation to Undo Systemic Harm in Preeclampsia
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Cedars-Sinai Medical Center
Collaborators
Alexion Pharmaceuticals, Inc.
Condition
Preeclampsia
Intervention
Eculizumab
Why stopped
PI moved institutions
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-29